LUCD Stock Price | Lucid Diagnostics Inc P/E, Revenue, EPS, & Forecasts

Lucid Diagnostics Inc • LUCD

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Lucid Diagnostics Inc

Ticker

LUCD

Trading on

NASDAQ

ISIN

US54948X1090

Industry

Medical Devices

Sector

Healthcare

CEO

Dr. Lishan Aklog M.D.

Headquarters

360 Madison Avenue, New York, NY, United States, 10017

Employees

Website

luciddx.com

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.

Metrics

BasicAdvanced

Market cap

$145M

P/E ratio

EPS

-$0.95

Dividend Yield

0.00%

Beta

1.22

Forward P/E ratio

EBIDTA

$-47.1M

Ex dividend date

Price & volume

Market cap

$145M

Average daily volume

0.6M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

33.26

Price to book

2.16

Earnings

EPS

-$0.95

EPS estimate (current quarter)

-$0.10

EPS estimate (next quarter)

-$0.10

EBITDA

$-47.1M

Revenues (TTM)

$4.4M

Revenues per share (TTM)

$0.06

Technicals

Beta

1.22

52-week High

$1.80

52-week Low

$0.75

50-day moving average

$1.14

200-day moving average

$1.22

Short ratio

2.53

Short %

3.12%

Management effectiveness

ROE (TTM)

-463.56%

ROA (TTM)

-82.33%

Profit margin

0.00%

Gross profit margin

$-2.6M

Operating margin

-978.85%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

19.20%

Share stats

Outstanding Shares

131M

Float

66.9M

Insiders %

33.67%

Institutions %

18.04%

Analyst Insights & forecasts

100% Buy

0% Hold

0% Sell

Based on information from 6 analysts.

Average price target

$3.75

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.20

-$0.22

9.09%

Q3 • 24Beat

-$0.19

-$0.17

-11.76%

Q4 • 24Missed

-$0.16

-$0.11

-41.22%

Q1 • 25Missed

-$0.10

-$0.11

9.09%

Q2 • 25Beat

-$0.10

-$0.11

6.28%

Q3 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$1.2M

$-4.4M

-381.69%

Q2 • 25

$1.21B

$-10.4B

-858.55%

Q3 • 25

104,027.26%

234,119.42%

124.94%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$38.7M

$30.8M

79.67%

Q2 • 25

$53.2B

$27.4B

51.44%

Q3 • 25

137,469.18%

88,717.84%

-35.44%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-10.5B

$-0M

$16.5B

$-10.5B

Q2 • 25

$-23.3B

$42.6B

$-23.3B

Q3 • 25

121.31%

158.54%

121.30%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Lucid Diagnostics Inc share?

Lucid Diagnostics Inc shares are currently traded for undefined per share.

How many shares does Lucid Diagnostics Inc have?

Lucid Diagnostics Inc currently has 131M shares.

Does Lucid Diagnostics Inc pay dividends?

No, Lucid Diagnostics Inc doesn't pay dividends.

What is Lucid Diagnostics Inc 52 week high?

Lucid Diagnostics Inc 52 week high is $1.80.

What is Lucid Diagnostics Inc 52 week low?

Lucid Diagnostics Inc 52 week low is $0.75.

What is the 200-day moving average of Lucid Diagnostics Inc?

Lucid Diagnostics Inc 200-day moving average is $1.22.

Who is Lucid Diagnostics Inc CEO?

The CEO of Lucid Diagnostics Inc is Dr. Lishan Aklog M.D..

How many employees Lucid Diagnostics Inc has?

Lucid Diagnostics Inc has 72 employees.

What is the market cap of Lucid Diagnostics Inc?

The market cap of Lucid Diagnostics Inc is $145M.

What is the P/E of Lucid Diagnostics Inc?

The current P/E of Lucid Diagnostics Inc is null.

What is the EPS of Lucid Diagnostics Inc?

The EPS of Lucid Diagnostics Inc is -$0.95.

What is the PEG Ratio of Lucid Diagnostics Inc?

The PEG Ratio of Lucid Diagnostics Inc is null.

What do analysts say about Lucid Diagnostics Inc?

According to the analysts Lucid Diagnostics Inc is considered a buy.